Jun Yu Gao

Dr. Jun Yu Gao


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2023 in Asian Journal of Psychiatry
Verified
Journal Article
Closed access
YZYi Zhong
Yi Zhong
YCYu-Jun Chen
Yu-Jun Chen
YZYang Zhou
Yang Zhou
YLYan-Ao-Hai Lyu
Yan-Ao-Hai Lyu
JYJiajun Yin
Jiajun Yin
JGJun Yu Gao
Jun Yu Gao

10 February 2023 in Asian Journal of Psychiatry
Verified
Journal Article
Open access
YZYi Zhong
Yi Zhong
JHJichao Huang
Jichao Huang
WZWen Zhang
Wen Zhang
SLShuiqing Li
Shuiqing Li
JGJun Yu Gao
Jun Yu Gao
The Coronavirus has infected up to 900 million people as of 11 Jan 2023 in China Mainland, which is more than 60% of the population. The sudden and unprecedented nature of pandemic has resulted in a range of psychosomatic issues among the population. These issues can manifest in a variety of ways and it is important to address these issues as they can have serious consequences for individuals' mental and physical health. The lifting of lockdown measures in China presents an opportunity to address these issues and provide support to those who have been affected.

3 June 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
YZYi Zhang
Yi Zhang
SWSan-Wang Wang
San-Wang Wang
JDJiahao Ding
Jiahao Ding
XWXin Wen
Xin Wen
TLTingting Li
Tingting Li
GSGuizhi Sun
Guizhi Sun

9 April 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
SHShihao Huang
Shihao Huang
SHShisheng Hao
Shisheng Hao
YSYue Si
Yue Si
DSDan Shen
Dan Shen
LCLan Cui
Lan Cui
XGXin Guo
Xin Guo

12 February 2024 in Depression and Anxiety
Verified
Journal Article
Open access
PDF file
YZYi Zhong
Yi Zhong
JLJianfeng Li
Jianfeng Li
HLHaitao Li
Haitao Li
MLMingzhe Li
Mingzhe Li
YLYanaohai Lyu
Yanaohai Lyu
JGJun Yu Gao
Jun Yu Gao
Objectives. It is a high risk for adolescents with first-episode major depressive disorder (MDD) to commit suicide. However, few studies reported the effect of modified electroconvulsive therapy (MECT) in first-episode antipsychotic-naive MDD adolescents. Methods. The study explores the alternations of regional homogeneity of modified electroconvulsive therapy to treat the first-episode antipsychotic-naive major depressive disorder. 72 first-episode MDD patients were recruited from Tianyou Hospital Affiliated to Wuhan University of Science and Technology from October 2017 to May 2020, and 65 of 72 completed the trial. Results. Before MECT treatment, ReHo values of the bilateral cerebellum and left cuneus were higher, and ReHo value of left postcentral and supramarginal gyrus was lower in MDD patients compared to healthy subjects (HS). After treatment, the MDD patients have higher ReHo values of the right insula and postcentral gyrus, while left fusiform gyrus were lower than the pretreatment. Compared to the HS, the ReHo values of left lingual gyrus, right calcarine cortex, and right mid occipital thalamus were higher in the posttreatment. In the posttreatment, left calcarine cortex and right cerebrum were lower than in healthy subjects. Conclusions. The study confirmed that MECT improves psychotic symptoms in patients with first-episode antipsychotic-naive MDD. These results further contributed to a more tailored treatment approach to MDD from the pathophysiological and neuroimaging views.

22 February 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
XLXiaobo Liu
Xiaobo Liu
BWBin Wan
Bin Wan
XWXinyu Wu
Xinyu Wu
XZXihan Zhang
Xihan Zhang
LLLang Liu
Lang Liu
JGJun Yu Gao
Jun Yu Gao
Adolescent major depressive disorder (MDD) involves complex and heterogeneous alterations in brain functional organization. A possible explanation is the disruption of individualized brain maturation during adolescence, which typically transitions from lower-order sensory to higher-order association regions. To test this hypothesis, we analyzed resting-state functional MRI data using advanced matrix decomposition techniques to extract organizational gradients, temporal dynamics, and information flow. Clustering sensory–association gradient features in our main sample (NMDD = 302 and NControls = 207; ages 11-17) revealed two subtypes. Subtype 1 showed bottom‑up (sensory‑to‑association) flow, reduced synergy but heightened redundancy in sensory cortices, and a highly modular yet globally inefficient network—patterns consistent with aberrant sensory processing and impaired integration. Subtype 2 instead displayed a top‑down (association‑to‑sensory) flow, reduced synergy in association areas, elevated redundancy in sensory regions, and network efficiency between subtype 1 and healthy controls, suggesting compensatory higher‑order engagement. Subtypes also differed in age-related changes, clinical profiles, and neurobiological processing. These patterns were largely replicated in an independent sample (NMDD = 73 and NControls = 28). Overall, the sensory-association axis distinguishes MDD subtypes, integrating functional heterogeneity, cortical dynamics, developmental trajectories, and genetic influences, offering new insights for pathophysiology and precision psychiatry.